Johnson & Johnson (JNJ) said on Tuesday that it has submitted a supplemental new drug application to the U.S. Food and Drug ...

A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced FDA approval for an update to its Varipulse platform's irrigation flow ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

H ealth care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug to treat patients aged 12 years and older with an immune-mediated disorder.

FDA issued an Early Alert for Abiomed's Automated Impella Controllers due to potential safety concerns following reports of 3 ...

The Food and Drug Administration has approved Johnson & Johnson’s Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis, a chronic disease of the ...

On Monday, the U.S. Food and Drug Administration issued a complete response letter (CRL) to Johnson & Johnson’s JNJ Biologics License Application for a fixed combination of amivantamab and ...

Health care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug to treat patients aged 12 years and older with an immune-mediated disorder.